Article
Pseudogene KRT17P3 Drives Cisplatin Resistance of Human NSCLC Cells by Modulating miR-497-5p/mTOR
2020-06-15
Abstract excerpt
<h4>Background: </h4> Chemoresistance is a major obstacle in non-small-cell lung cancer (NSCLC) treatment. The pseudogene KRT17P3 has been shown to be up-regulated in lung cancer tissues from patients with cisplatin resistance. However, its molecular mechanism in promoting chemoresistance has not been elucidated. <h4>Methods: </h4>: Real-time PCR was performed to evaluate KRT17P3 levels in plasma samples collected...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f035fe09-bb90-55d9-bdec-859f11a99a40
- DOI
- 10.21203/rs.3.rs-34675/v1
